ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-ß copathology. (2019)
Attributed to:
Further defining the genetic architecture of Alzheimer's disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.40416
Publication URI: https://www.repository.cam.ac.uk/handle/1810/293264
Type: Journal Article/Review